These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 18948497)

  • 1. Farnesoid X receptor deficiency induces nonalcoholic steatohepatitis in low-density lipoprotein receptor-knockout mice fed a high-fat diet.
    Kong B; Luyendyk JP; Tawfik O; Guo GL
    J Pharmacol Exp Ther; 2009 Jan; 328(1):116-22. PubMed ID: 18948497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FXR deficiency causes reduced atherosclerosis in Ldlr-/- mice.
    Zhang Y; Wang X; Vales C; Lee FY; Lee H; Lusis AJ; Edwards PA
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2316-21. PubMed ID: 16825595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis.
    Wouters K; van Gorp PJ; Bieghs V; Gijbels MJ; Duimel H; Lütjohann D; Kerksiek A; van Kruchten R; Maeda N; Staels B; van Bilsen M; Shiri-Sverdlov R; Hofker MH
    Hepatology; 2008 Aug; 48(2):474-86. PubMed ID: 18666236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice.
    Gupte AA; Liu JZ; Ren Y; Minze LJ; Wiles JR; Collins AR; Lyon CJ; Pratico D; Finegold MJ; Wong ST; Webb P; Baxter JD; Moore DD; Hsueh WA
    Hepatology; 2010 Dec; 52(6):2001-11. PubMed ID: 20938947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice.
    Depner CM; Torres-Gonzalez M; Tripathy S; Milne G; Jump DB
    J Nutr; 2012 Aug; 142(8):1495-503. PubMed ID: 22739374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.
    Depner CM; Philbrick KA; Jump DB
    J Nutr; 2013 Mar; 143(3):315-23. PubMed ID: 23303872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of FXR protects against diet-induced obesity and accelerates liver carcinogenesis in ob/ob mice.
    Zhang Y; Ge X; Heemstra LA; Chen WD; Xu J; Smith JL; Ma H; Kasim N; Edwards PA; Novak CM
    Mol Endocrinol; 2012 Feb; 26(2):272-80. PubMed ID: 22261820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice.
    Subramanian S; Goodspeed L; Wang S; Kim J; Zeng L; Ioannou GN; Haigh WG; Yeh MM; Kowdley KV; O'Brien KD; Pennathur S; Chait A
    J Lipid Res; 2011 Sep; 52(9):1626-35. PubMed ID: 21690266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).
    Sharma RS; Harrison DJ; Kisielewski D; Cassidy DM; McNeilly AD; Gallagher JR; Walsh SV; Honda T; McCrimmon RJ; Dinkova-Kostova AT; Ashford MLJ; Dillon JF; Hayes JD
    Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):367-398. PubMed ID: 29552625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat/sugar diet.
    Liu X; Henkel AS; LeCuyer BE; Schipma MJ; Anderson KA; Green RM
    Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(12):G965-74. PubMed ID: 26472223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
    Gillard J; Clerbaux LA; Nachit M; Sempoux C; Staels B; Bindels LB; Tailleux A; Leclercq IA
    JHEP Rep; 2022 Jan; 4(1):100387. PubMed ID: 34825156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice.
    Hanniman EA; Lambert G; McCarthy TC; Sinal CJ
    J Lipid Res; 2005 Dec; 46(12):2595-604. PubMed ID: 16186601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.
    Schmitt J; Kong B; Stieger B; Tschopp O; Schultze SM; Rau M; Weber A; Müllhaupt B; Guo GL; Geier A
    Liver Int; 2015 Apr; 35(4):1133-1144. PubMed ID: 25156247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?
    Lytle KA; Jump DB
    PLoS One; 2016; 11(1):e0146942. PubMed ID: 26761430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.
    Lytle KA; Wong CP; Jump DB
    PLoS One; 2017; 12(4):e0173376. PubMed ID: 28422962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response.
    Wang YD; Chen WD; Wang M; Yu D; Forman BM; Huang W
    Hepatology; 2008 Nov; 48(5):1632-43. PubMed ID: 18972444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ageing Fxr deficient mice develop increased energy expenditure, improved glucose control and liver damage resembling NASH.
    Bjursell M; Wedin M; Admyre T; Hermansson M; Böttcher G; Göransson M; Lindén D; Bamberg K; Oscarsson J; Bohlooly-Y M
    PLoS One; 2013; 8(5):e64721. PubMed ID: 23700488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development.
    Maran RR; Thomas A; Roth M; Sheng Z; Esterly N; Pinson D; Gao X; Zhang Y; Ganapathy V; Gonzalez FJ; Guo GL
    J Pharmacol Exp Ther; 2009 Feb; 328(2):469-77. PubMed ID: 18981289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease.
    Bieghs V; Van Gorp PJ; Wouters K; Hendrikx T; Gijbels MJ; van Bilsen M; Bakker J; Binder CJ; Lütjohann D; Staels B; Hofker MH; Shiri-Sverdlov R
    PLoS One; 2012; 7(1):e30668. PubMed ID: 22295101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.